Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialW. Timothy Garvey, Anuj Bhargava, Juan P. Frías et al.|The Lancet|2023Cited by 676
Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th editionИ. И. Дедов, Ekaterina А. Shestakova, Zera N. Dzhemilova et al.|Diabetes Mellitus|2019Cited by 257
The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)И. И. Дедов, G. R. Galstyan, Marina V. Shestakova|Diabetes Mellitus|2016Cited by 254
Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022И. И. Дедов, Н. Г. Мокрышева, Marina V. Shestakova et al.|Diabetes Mellitus|2023Cited by 248
Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th EditionИ. И. Дедов, M. V. Yaroslavceva, Marina V. Shestakova et al.|Diabetes Mellitus|2023Cited by 206